In this study, Chao et al. analyzed systematically Hfq-bound RNAs of Salmonella Typhimurium at various growth stages by deep sequencing. They found that at least 8 new small RNAs are generated from the 3' region of mRNAs. One of newly identified sRNAs, DapZ, was characterized in some detail. It overlaps with the 3' region of dapB mRNA. Evidence indicates that DapZ is transcribed from a promoter located in the 3' region of dapB gene and regulated by HilD, the master regulator of Salmonella invasion genes. The authors also showed evidence that DapZ uses GcvB-like pairing region to negatively regulate translation of DppA and OppA which are the well-known targets of GcvB. Some of the newly identified sRNAs appear to be generated from the processing of the fulllength cognate mRNAs.
This work is the first to demonstrate that Hfq-binding sRNAs can be produced from the 3' region of mRNAs either by transcription from an internal promoter or by processing of a full-length mRNA. The data and arguments are mostly convincing to support the conclusion. The finding expanded our view regarding how bacterial Hfq-binding sRNAs are generated in bacterial cells.
Comments:
1) The effect of dapZ deletion on dppA::lacZ expression is detected only when gcvB is disrupted together. What is the possible explanation for this observation?
2) The authors argue that some of sRNAs such as STnc840, STnc870, and STnc2090 may be generated by processing of the full-length mRNAs. They suggested that RNase E recruited by Hfq might be involved in the processing. It is interesting to test whether the truncation of C-terminal scaffold region affects the processing. 3) Do authors exclude the possibility that STnc840, STnc870, and STnc2090 are produced from internal promoters? 4) The authors argue that the base-pairing regions are conserved while the Hfq-binding sites are much less conserved among sRNAs. This view is rather confusing for me because the diversity but not conservation of base-pairing region should explain the target specificity of sRNAs while the Hfq-binding sites including the rho-independent terminator are fairly well conserved at least regarding 3' polyU stretch and their hairpin structures.
Referee #2
The Vogel lab has discovered a novel facet of regulatory RNA metabolism in bacteria: deep sequencing of Hfq-binding RNAs isolated from Salmonella typhimurium cells at different growth stages of has pinpointed the 3'-UTR of bacterial mRNAs as a rich source of regulatory sRNAs. In some cases, growth phase-dependent sRNA expression correlates with that of the "host" mRNA, in other cases not. In the DpaZ RNA case studied in detail here, the 3'-UTR of the conserved dapB mRNA was found to harbour an internal promoter close to the Rho-independent terminator, which directs sRNA transcription independent of dapB mRNA expression. The authors further identified HilD, the master regulator of Salmonella invasion genes, as the key factor to induce DapZ RNA expression from the internal promoter. The authors also identified the mRNAs for the major ABC transporters DppA and OppA as targets that are negatively regulated by DapZ. These target regions coincide with those for another sRNA, GcvB. The functional G/U-rich region is shared between DapZ and GcvB, supporting a concept to classify also bacterial sRNAs on the basis of biologically relevant "seed" regions. The mansucript reports a very competent, sound, comprehensive and fascinating investigation on bacterial regulatory RNAs, with novel specific findings on DapZ RNA exerting a regulatory function that is interdigitated with the pathogenicity of S. typhimurium. I think the paper is very suitable for publication in The EMBO Journal. Some points, mainly minor and detailed below, should yet be addressed before publication.
Major points: 1) p. 5, line 12: "... Spot42 (Spf) sRNA prevails ..." Otherwise the reader inspects Fig. 1B and is unable to find "Spot42". 2) p. 6, 3rd paragraph, line 5: I cannot infer from Fig. 1B that expression of STnc840 sharply peaks at a OD600 of 2. 3) Fig. 3C : how do you explain the appearance of a RACE product also in the "-TAP" lane? Could it be that DapZ RNA is also released fom dapB transcripts by endonucleolytic processing? Or does this simply reflect some nibbling at 5'-PPP termini to yield 5'-P ends, eihter occuring intracellularly or during RNA isolation? 4) p. 9, 2nd paragraph, and Fig. 5C : how do you explain that the dppA::lacZ reporter is not affected at all in the Delta_dapZ strain? The authors should discuss one or more possible explanations; one is that, when GcvB is present, it occupies the target site owing to its more stable binding relative to DapZ, but DapZ "gets a chance" to bind and moderately suppress when its competitor GcvB RNA is absent. 5) p. 11, last 4 lines: the recovery of SdsR appears to be high at +6 and +9 h, in contrast to what is stated here. 6) Fig. 6C and Fig. S7 : in the legend to Fig. 6C you say " A structure rearrangement in dppA is labelled with *". What about the possibility that the second protection region is a second target site of DapZ on dppA? In Fig. S7 , two complexes form between the labeled dppA leader and titrated DapZ RNA; might the faster migrating one be a 1:1 complex, and the slower migrating a 2:1 (2 DapZ: 1 dppA) complex? Also, the first complexes between DapZ* and titrated dppA leader in panel B appear at 4 nM, the same concentration at which the first faster migrating complexes appear in panel A (dppA*, excess DapZ). I propose that the authors discuss this issue and add a few sentences to the text addressing this point.
Minor points: 7) p. 8, last two lines: what do you mean by "... this becomes even more prominent when the criteria for differential expression is relaxed (Table S3) ." ? 8) p. 11, 2nd paragraph, line 8 from bottom: I do not see 20% DapZ reads, rather 11-12%. 9) Legend to Fig. 4 : -line 6 from bottom: "(C) Western blot analysis of GFP reporters in which dapZ homologues from several related enterobacteria were fused to a promoterless gfp gene: ..." -line 3 from bottom: "... as well as the pBAD-hilD plasmid (hilD) were grown in LB for 2 h in the presence ..." -also explain PompC and PhilA, e.g. "PompC and PhilA are promoter regions known to be responsive (PhilA) or non-responsive (PompC) to HilD." 10) Legend to 
Referee #3
This ambitious study by Chao, et al., identified novel sRNA candidates in Salmonella by deep sequencing of transcriptomes from different growth phases. The study nicely illustrates that the catalog of sRNAs, even for one of the best-studied bacterial model organisms, is still not complete.
The study presents evidence for a rather new class of sRNA regulators, those derived from 3' untranslated regions of bacterial genes. The expression of a good proportion of the 3' UTR sRNAs identified by deep sequencing was verified by Northern blot, and the authors went on to characterize one of these, DapZ, in more depth. The major results of this characterization were: 1) identification of a dapZ promoter that is regulated by the major Salmonella virulence regulator, HilD; 2) identification of candidate DapZ mRNA targets by pulse expression; 3) validation of two DapZ target mRNAs, which are also known targets of another sRNA, GcvB. Overall, this was an excellent study. I have a few issues described below. If these were addressed, I think the study might be a bit more coherent and have more impact.
Major issues:
• My main issue is that the authors seem to be trying to argue both sides with respect to the relevance of DapZ's location downstream of the dapB gene. They say that since dapB mRNA and DapZ have different patterns of expression and dapZ is transcribed from an independent promoter, the two RNAs almost certainly have independent functions (p. 6-7). On the other hand, a major argument for the novelty of this system is that DapZ is a 3' UTR-derived RNA (Discussion, p. 10, . My interpretation of the data is that DapZ is a trans-encoded sRNA whose location happens to overlap with the 3' UTR of a well-conserved metabolic gene. The data presented actually argue against its being derived from dapB mRNA's 3' UTR. As mentioned below, I think this could be explored further, but in the absence of additional experiments, I think the authors need to reframe the significance.
• I think the relationship of dapB and dapZ merits further investigation. Are there conditions under which dapZ expression affects dapB expression or vice versa? The authors know conditions that should induce each of these genes. When dapB is highly expressed, does the dapB mRNA get processed to yield the same or a DapZ with a different 5' end? There are hints in 5' RACE ( Fig. 3C ) and Northern blots (Fig. 2, S5 ) that there are multiple DapZ species, and in fact at later timepoints ( Fig. S5, OD2+2h ), the shorter forms accumulate preferentially over the longest form. Are those processed forms of DapZ derived from dapB mRNA?
• An interpretation for the other bands in 5' RACE ( Fig. 3C , -TAP) and Northern blots (Figs. 4AB, S5) should be presented. These might be processed products from dapB mRNA? They might be functionally relevant.
• Fig. 5B : Control(s) for DapZ R1 mutant should be provided-is its structure/stability similar to wild-type DapZ? • p. 9, 2nd paragraph: The authors state at the end of the paragraph, "...expression of dapB mRNA was unaffected by the ΔdapZ mutation ( Fig. S6) , ruling out the possibility of indirect effects through an impaired metabolic function of DapB." The dapB mRNA levels appear to have been assayed at a single timepoint, which does not address this issue sufficiently to make such a strong statement. Further, it's possible that DapZ could affect dapB post-transcriptionally, and DapB protein levels were not examined. (This is relevant to the point above regarding further characterization of the relationship between dapZ and dapB.) As is, this conclusion is an overinterpretation of the data.
Minor issues:
• There is some awkward or incorrect grammer in various places in the manuscript. Missing a few articles here, and there, especially "the". See also the first sentence of the discussion for an example of awkward wording.
• 2nd paragraph, p. 12: The authors rationalize HilD activation of dapZ as a way for cells to selectively repress ABC transporters during invasion without the need to invoke GcvB, which would repress a larger regulon, including aa uptake and synthesis functions. I'm not sure how meaningful this is-the assays shown in Fig. 5C show that under DapZ inducing conditions (OD 2), GcvB still plays a bigger role in translational repression of at least Opp and Dpp than DapZ.
• Fig. 5B . I would rather see fold-changes than colors. It would make the data easier for me to interpret. Reply: One possible explanation is that, when GcvB is present, it occupies the target site owing to its more stable binding/abundance relative to DapZ. In this scenario, DapZ would only have a chance to bind and suppress its targets when the competitor GcvB sRNA is absent, so that DapZ--mediated repression of dppA is only detectable in the gcvB deletion strain. Arguably, there might be certain physiological conditions when GcvB expression is low while that DapZ is high, so DapZ becomes the major regulator, relative to GcvB. This is now briefly discussed in the text on page 9.
2) The authors argue that some of sRNAs such as STnc840, STnc870, and STnc2090 may be generated by processing of the full--length mRNAs. They suggested that RNase E recruited by Hfq might be involved in the processing. It is interesting to test whether the truncation of C--terminal scaffold region affects the processing.
Reply: The referee raises the interesting question whether the C--terminus of RNase E, which both organizes degradosome assembly and mediates complex formation with Hfq, is required for the generation of the 3' UTR--derived sRNAs, which are formed by the processing of the corresponding mRNAs. Using a Salmonella strain that allowed us to inactivate RNase E by temperature shift of the culture, we have indeed confirmed our prediction that RNase E is essential for the processing of several of these sRNAs. This data provides evidence for the second pathway of biogenesis of 3' UTR--derived sRNAs (shown to the right in Fig. 7 ) and is currently being prepared for publication. A detailed analysis of the expression and processing changes of these sRNAs in several different mutant strains of RNase E, including the C--terminus deficient rne701 strain will be presented in this follow--up paper.
3) Do authors exclude the possibility that STnc840, STnc870, and STnc2090 are produced from internal promoters? Reply: Yes, we tend to exclude the possibility that these sRNAs are produced from internal promoters based on three lines of evidences. First, inspection of their 5' end status using the differential RNA--seq data (Kröger et al. 2012 and additional unpublished data from the Vogel and Hinton labs) suggests that the these sRNAs carry a 5' monophosphate end, a hallmark for processed RNA products. Second, and this may be even stronger evidence, we have cloned these sRNA regions along with their upstream mRNA coding--sequence (CDS) into high--copy vectors. If a promoter was present in the upstream CDS, this would result in the overproduction of these sRNAs owing to a high--copy effect. However, we did not observe such an overproduction. Third, all these sRNAs lack recognizable promoter consensus sequences (--35 and --10 boxes) within several hundred base pairs upstream of the determined 5' end. This data will be presented in the above--mentioned follow--up paper that will report the RNA processing activity that underlies the biogenesis of these promoterless sRNAs. Fig. 1B . In addition, to facilitate the interpretation of the results from this part of the manuscript, we have included in the revised version a supplementary EXCEL file containing the fraction of reads for the individual sRNAs in the Hfq CoIP (Table  S3) .
3) Fig. 3C: how do you explain the appearance of a RACE product also in the "--TAP" lane? Could it be that DapZ RNA is also released fom dapB transcripts by endonucleolytic processing? Or does this simply reflect some nibbling at 5'--PPP termini to yield 5'--P ends, eihter occuring intracellularly or during RNA isolation?
Reply: The appearance of a (nota bene, weaker) RACE signal in the "--TAP" lane is not unexpected and has indeed been observed for many other primary sRNAs before, for example, SroH, RyeB and RygB (Vogel et al. 2003 NAR, 31: 6435--6443) . A straight--forward explanation is that the 5'PPP--group of the primary sRNA transcript is a substrate for RppH or another of the many pyrophosphohydrolases of the Nudix enzyme family that are encoded by γ--proteobacteria such as E. coli and Salmonella (Deana A et al. 2008 Nature 451(7176):355--8.) . This means that a fraction of 5'PPP ends are converted to 5'P ends in vivo, and thus can be amplified by 5'RACE without prior treatment with tobacco acid pyrophosphate (TAP). Therefore, it is the increase in signal upon RNA treatment with TAP (in the TAP+ lane), resulting from the conversion of the remaining 5'PPP groups to 5'P that we take as evidence for a primary transcript end. The other, shorter RACE product in TAP--lane represents a processing intermediate of DapZ, and as expected, is not found in the TAP+ reaction. By cloning and sequencing the 5' RACE products from the TAP--lane, we have mapped this internal processing to U12 of the DapZ RNA. These explanations have been added to the legend of Figure 3 .
4) p. 9, 2nd paragraph, and Fig. 5C: how do you explain that the dppA::lacZ reporter is not affected at all in the Delta_dapZ strain? The authors should discuss one or more possible explanations; one is that, when GcvB is present, it occupies the target site owing to its more stable binding relative to DapZ, but DapZ "gets a chance" to bind and moderately suppress when its competitor GcvB RNA is absent.
Reply: We agree with the referee's explanation and have added this to the text on page 9.
5) p. 11, last 4 lines: the recovery of SdsR appears to be high at +6 and +9 h, in contrast to what is stated here.
Reply: SdsR is only lowly expressed in early stationary phase (OD600 of 2), which is the relevant growth condition for this part of the text, as stated in the preceding sentence. In our previous work (Fröhlich et al, NAR, 2012) , we determined ~20 SdsR copies/cell under this growth condition. Therefore our statement that SdsR and ArcZ exhibit low recovery than DapZ and InvR is correct. Later during growth when the copy number of SdsR rises to ~200 to 300 we also recover more reads for this sRNA. Fig. 6C and Fig. S7 : in the legend to Fig. 6C We are grateful to the reviewer for the suggestion. We tentatively exclude that the second protection site is another targeting site, because the GAGUAUUUCCUU nucleotides (+3 to +14 of dppA) involved in the structural rearrangement do not seem to have complementarity with regions in the DapZ sRNA. Based on the extensive changes of cleavage patterns (both increased and decreased) in this area, we favour the explanation that there is a structural rearrangement of the mRNA upon addition of DapZ; this would also explain the difference in migration of dppA leader RNA in native gels. As per the referee's request, we have added these considerations into the legend of Fig. 6 in the revised manuscript.
6)
Minor points:
7) p. 8, last two lines: what do you mean by "... this becomes even more prominent when the criteria for differential expression is relaxed (Table S3)." ?
Reply: This sentence is no longer valid (because Table S3 has been replaced by a new Supplementary  Table S5 as per request by referee #3) and has been deleted in the revised manuscript.
8) p. 11, 2nd paragraph, line 8 from bottom: I do not see 20% DapZ reads, rather 11--12%.
Reply: The referee is right and we sincerely apologise for the lapse, which resulted from failure to correct the text after final data analysis. We have corrected the read number to 12%.
9) Legend to Fig. 4: --line 6 from bottom: "(C) Western blot analysis of GFP reporters in which dapZ homologues from several related enterobacteria were fused to a promoterless gfp gene: ..." --line 3 from bottom: "... as well as the pBAD--hilD plasmid (hilD) were grown in LB for 2 h in the presence ..." --also explain PompC and PhilA, e.g. "PompC and PhilA are promoter regions known to be responsive (PhilA) or non--responsive (PompC) to HilD."
Reply: All of the above corrected. Fig. 6D : explain what the controls are. Also, can you offer an explanation why the dapZM1 constructs give increased fluorescence relative to the controls in the gfp, oppA and dppA cases? Reply: The description of controls has been added to the legend of Figure 6D . There are two possible explanations why the M1 constructs display increased fluorescence over the respective wild--type reporters. First, the reporter experiment was carried out in a gcvB dapZ double deletion strain, to exclude regulation by the chromosomal sRNA loci. However, we cannot exclude the possibility that yet another sRNA exists that binds and represses dppA and oppA in the same regions as DapZ and GcvB. Regulation by this hypothetical sRNA would be lost with the M1 mutant reporters, resulting in higher basal activity/fluorescence. Second, the M1 mutation near the translation initiation region might fortuitously result in higher basal translation of the dppA and oppA reporters, for example, by improving the structural accessibility for ribosome binding. Generally, having constructed a couple of dozen reporters with point mutations in sRNA binding regions over the last few years, we have often seen such fortuitous increased basal reporter activity, and so have others (e.g., ompC::luc reporter in Chen S, Zhang A, Blyn LB, Storz G 2004 J Bac 186(20):6689--97) . So, while the observation is interesting, it may require a deeper investigation. p. 10, Reply: We absolutely agree with the referee that DapZ is not derived from the 3' UTR of the dapB mRNA, whereas it clearly is a trans--encoded sRNA transcribed from the DNA region corresponding to the 3' UTR of the dapB gene. In fact, this is one of the main messages of the manuscript, and Fig. 3 and 4 provide strong evidence that DapZ is an independent transcript. We assume that part of the misunderstanding may result from nomenclature: for simplicity, we refer to 3' UTR as either the DNA or RNA region that follows the coding sequence of the respective gene. The fact that the dapZ gene tightly overlaps the 3'UTR of dapB is novel, indeed (and certainly as novel as if DapZ were derived from the 3' UTR of the dapB mRNA), because such sRNA genes have been systematically overlooked in previous studies. To further improve the clarity of our manuscript, we have added a brief statement regarding our use of the term "3'UTR" on page 6.
10) Legend to

I think the relationship of dapB and dapZ merits further investigation. Are there conditions under which dapZ expression affects dapB expression or vice versa?
The authors know conditions that should induce each of these genes. Reply: In our manuscript, we argue that the expression of dapB and DapZ is independent since they have completely different transcriptional control and are involved in different biological pathways.
Inferring from E. coli data (Bouvier et al, , dapB should be highly expressed in minimal media in which lysine is scarce; however, under this condition HilD and thus DapZ sRNA will not be expressed, which precludes a direct investigation of the impact of high dapB expression on DapZ. However, to explore a possible relationship of dapB and DapZ expression, we analyzed a RNA--seq data set for Fig. 3C would lack the first few nucleotides of the DapZ seed region (cleavage at U12) and is thus very likely impaired in target interactions. The next shorter processed DapZ would lack the seed region entirely and so be fully inactive in terms of oppA and dppA regulation. Why at later time points the shorter forms accumulate preferentially over the functional fulllength species is currently unknown. One reasonable explanation, however, is that these shorter species are stable intermediates of intrinsic, unregulated decay; whereas the full--length DapZ species undergoes coupled degradation with the dppA and oppA mRNA targets, and the rate of this decay increases as the expression of GcvB-the other sRNA to regulate these target-strongly declines in stationary phase. We briefly discuss these issues in the revised version of the manuscript (page 7). Figure S12 in the revised manuscript. The results confirm that DapZ--DR1 RNA accumulated to the same level as the wildtype DapZ RNA. Moreover, the DR1 mutation is unlikely to affect the overall secondary structure since the R1 region is located in a single stranded region of the sRNA (Fig. 3A) .
p. 9, 2nd paragraph: The authors state at the end of the paragraph, "...expression of dapB mRNA was unaffected by the dapZ mutation (Fig. S6) Reply: As discussed, we consider DapZ an emerging regulator that has just been integrated into regulatory network of Salmonella genes, so it may still be able to evolve to the same regulatory power as the widely conserved GcvB sRNA. Nonetheless, the experiments in this study were done in laboratory medium, and we do not exclude the possibility that DapZ plays a bigger role than GcvB under certain natural environmental conditions, for example, in gut lumen of infected mammals when GcvB expression is expected to be marginal. Future experiments will address sRNA--mediated gene regulation in Salmonella under such infection conditions.
Fig. 5B. I would rather see fold--changes than colors. It would make the data easier for me to interpret.
Reply: The fold--change values are now provided in the new Supplementary Table S5 (which replaces the  previous, redundant Table S3 ).
Acceptance letter 19 July 2012
Thank you for submitting your revised manuscript to the EMBO Journal. I asked referee #3 to take a look at the revision and I have now received the comments back. As you can see below, referee #3 appreciates the introduced changes and support publication in the EMBO Journal. I am therefore very pleased to proceed with the acceptance of the study and I am happy to see the paper published here. You will receive the formal acceptance letter shortly.
Thank you for considering us for the publication of your work!
Yours sincerely Editor
The EMBO journal REFEREE REPORT Referee #3 I am satisfied with the authors' revisions and think that this manuscript should be published in EMBO.
